Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177): primary endpoint results, effect estimate…
- Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689): primary endpoint results, effect estimate…
- Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02998268).
- Study of Pembrolizumab in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine: Integration of Molecular Subtypes Through Integrative Genomic Analysis: Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine: Integration of Molecular Subtypes Through Integrative Genomic…
- Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033/KEYNOTE-033): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033/KEYNOTE-033): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006): primary endpoint results, effect estimate with confidence interval,…
- Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been…
- Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789): Complete Statistical AnalysisIndependent statistical analysis of Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung…
- Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)-Japan Extension Study: Complete Statistical AnalysisIndependent statistical analysis of Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)-Japan Extension Study: primary endpoint results, effect estimate…
- Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms: Complete Statistical AnalysisIndependent statistical analysis of Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies: Complete Statistical AnalysisIndependent statistical analysis of Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies: primary endpoint results, effect estimate with confidence…
- STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT: Complete Statistical AnalysisIndependent statistical analysis of STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- STUDY OF PF-07321332 IN HEALTHY PARTICIPANTS: Complete Statistical AnalysisIndependent statistical analysis of STUDY OF PF-07321332 IN HEALTHY PARTICIPANTS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04756531).
- Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Phasix™ Mesh for VHWG Grade 3 Midline Hernia Repair: Complete Statistical AnalysisIndependent statistical analysis of Study of Phasix™ Mesh for VHWG Grade 3 Midline Hernia Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006: Complete Statistical AnalysisIndependent statistical analysis of Study of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Picosecond and Nanosecond Q-switched Lasers for Tattoo Removal: Complete Statistical AnalysisIndependent statistical analysis of Study of Picosecond and Nanosecond Q-switched Lasers for Tattoo Removal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01973166).
- Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia: Complete Statistical AnalysisIndependent statistical analysis of Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury: Complete Statistical AnalysisIndependent statistical analysis of Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury: primary endpoint results, effect estimate with confidence interval,…
- Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function.: Complete Statistical AnalysisIndependent statistical analysis of Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant: Complete Statistical AnalysisIndependent statistical analysis of Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of PM Modulation Therapy in Trial Phase: Complete Statistical AnalysisIndependent statistical analysis of Study of PM Modulation Therapy in Trial Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03110601).
- Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia: Complete Statistical AnalysisIndependent statistical analysis of Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment: Complete Statistical AnalysisIndependent statistical analysis of Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Prasugrel in Korean Healthy Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Study of Prasugrel in Korean Healthy Male Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01591317).
- Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD: Complete Statistical AnalysisIndependent statistical analysis of Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062): Complete Statistical AnalysisIndependent statistical analysis of Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition Insecurity: Complete Statistical AnalysisIndependent statistical analysis of Study of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition Insecurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment: Complete Statistical AnalysisIndependent statistical analysis of Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer: primary…
- Study of Propranolol as Anti-Adhesive Therapy in Sickle Cell Disease (SCD): Complete Statistical AnalysisIndependent statistical analysis of Study of Propranolol as Anti-Adhesive Therapy in Sickle Cell Disease (SCD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC: Complete Statistical AnalysisIndependent statistical analysis of Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Quadrivalent Influenza Vaccine Among Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of Quadrivalent Influenza Vaccine Among Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01218646).
- Study of Quadrivalent Influenza Vaccine Among Children: Complete Statistical AnalysisIndependent statistical analysis of Study of Quadrivalent Influenza Vaccine Among Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01240746).
- Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B: Complete Statistical AnalysisIndependent statistical analysis of Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive…
- Study of Ramucirumab in Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Ramucirumab in Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00721162).
- Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD): Complete Statistical AnalysisIndependent statistical analysis of Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Rapastinel as Monotherapy in Patients With MDD: Complete Statistical AnalysisIndependent statistical analysis of Study of Rapastinel as Monotherapy in Patients With MDD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03560518).
- Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS): Complete Statistical AnalysisIndependent statistical analysis of Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older: Complete Statistical AnalysisIndependent statistical analysis of Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older: primary endpoint…